Kura Oncology, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for KURA, updated each market day.
KURA AI Sentiment
AI sees no strong directional signal for Kura Oncology, Inc. stock over the next 10 market days.
Prediction date: May 7, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Kura Oncology, Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Sector
Exchange
Market Cap
$783,774,676
Cap Tier
Employees
260
Headquarters
SAN DIEGO, CA
Listed Since
Aug. 25, 2015
Website
KURA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KURA Volatility
Kura Oncology, Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
